Stockreport

How Investors Are Reacting To Incyte (INCY) EMA Boost For Zynyz In First-Line Anal Cancer [Yahoo! Finance]

Incyte Corporation  (INCY) 
Last incyte corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: incyte.com/ir/investor-overview.aspx
PDF chemotherapy as first-line treatment for adults with metastatic or inoperable locally recurrent squamous cell carcinoma of the anal canal, based on Phase 3 data showing [Read more]